Angiodynamics (ANGO) EBIT Growth (3y) (2013 - 2026)
Angiodynamics (ANGO) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.16 Bn | 128.94 Bn | 1.96 Bn | 28.02% |
| 2 | Becton Dickinson | 52.48 Bn | 51.61 Bn | 2.32 Bn | 6.49% |
| 3 | Alcon | 35.70 Bn | 34.34 Bn | 1.68 Bn | -73.35% |
| 4 | Resmed | 33.66 Bn | 32.19 Bn | 861.22 Mn | 17.69% |
| 5 | Medline | 29.16 Bn | 26.48 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.61 Bn | 329.20 Mn | -0.62% |
| 7 | Solventum | 15.37 Bn | 14.96 Bn | 1.29 Bn | -24.29% |
| 8 | Cooper Companies | 14.79 Bn | 14.65 Bn | 735.40 Mn | -32.42% |
| 9 | Baxter International | 13.57 Bn | 11.42 Bn | 1.03 Bn | 145.32% |
| 10 | Angiodynamics | 652.37 Mn | 598.51 Mn | 46.77 Mn | 21.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 21.20% |
| Feb 28, 2026 | -13.20% |
| Nov 30, 2025 | 8.95% |
| Aug 31, 2025 | 7.12% |
| May 31, 2025 | 3.28% |
| Feb 28, 2025 | -23.50% |
| Nov 30, 2024 | -8.53% |
| Aug 31, 2024 | -17.37% |
| May 31, 2024 | 12.53% |
| Feb 29, 2024 | -276.75% |
| Nov 30, 2023 | -39.47% |
| Aug 31, 2023 | 106.76% |
| May 31, 2023 | 48.95% |
| Feb 28, 2023 | -12.71% |
| Nov 30, 2022 | -33.34% |
| Aug 31, 2022 | -152.32% |
| May 31, 2022 | -61.10% |
| Feb 28, 2022 | -12.96% |
| Nov 30, 2021 | -50.88% |
| Aug 31, 2021 | -9.74% |